Merck KGaA (FRA:MRK) received a €115.00 ($136.90) price target from stock analysts at Warburg Research in a report issued on Wednesday. The brokerage currently has a “buy” rating on the healthcare company’s stock.

Several other equities research analysts have also weighed in on the stock. BNP Paribas set a €116.00 ($138.10) target price on shares of Merck KGaA and gave the stock a “buy” rating in a report on Wednesday. Goldman Sachs Group, Inc. (The) set a €105.00 ($125.00) target price on shares of Merck KGaA and gave the stock a “neutral” rating in a report on Wednesday. Societe Generale set a €103.00 ($122.62) target price on shares of Merck KGaA and gave the stock a “neutral” rating in a report on Tuesday, September 5th. equinet AG set a €112.00 ($133.33) target price on shares of Merck KGaA and gave the stock a “buy” rating in a report on Thursday, August 31st. Finally, Independent Research GmbH set a €105.00 ($125.00) target price on shares of Merck KGaA and gave the stock a “neutral” rating in a report on Monday, August 28th. Fourteen analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of €107.71 ($128.23).

Merck KGaA (FRA MRK) traded up 0.022% during trading on Wednesday, reaching €95.623. 1,786 shares of the company’s stock traded hands. The firm’s 50 day moving average is €93.50 and its 200 day moving average is €102.64. The company has a market cap of €41.57 billion and a P/E ratio of 24.928. Merck KGaA has a 12 month low of €89.00 and a 12 month high of €115.00.

TRADEMARK VIOLATION WARNING: This piece was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another site, it was illegally copied and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/09/10/merck-kgaa-mrk-given-a-115-00-price-target-by-warburg-research-analysts.html.

Merck KGaA Company Profile

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.